Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings 
SK Hynix’s $28 Billion U.S. Share Sale Draws Massive Demand Amid AI Chip Boom 
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results 
Zhipu AI Stock Jumps on Report of Custom AI Chip Development Plans 
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate 
Lockheed Martin, Rheinmetall Plan First ATACMS Missile Production in Germany 
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest 
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia 
Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns 
Apple Tests China's CXMT Memory Chips as DRAM Maker Gains Global Market Share 
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge 
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow 
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion 
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement 
SpaceX Stock Draws Bullish Wall Street Coverage Ahead of Nasdaq-100 Inclusion 
TetherMax Rebranding Highlights Official Exchange Partnerships and Transparent Operations 
TEANECK, N.J., May 07, 2018 -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on June 27, 2018, to stockholders of record at the close of business on June 6, 2018.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. For further information, please visit www.pahc.com.
Contact:
Richard Johnson
Chief Financial Officer, Phibro Animal Health Corporation
+1 201-329-7300
[email protected]
